Press-release for stocks related to expansion

Prices are updated after-hours

| -73.92% | O: -20.18% H: 0.0% C: -9.63%
stro-002 biopharma expansion ovarian cancer phase 1 cancer

2022 KOL Discussion of STRO-002 Phase 1 Interim Dose Expansion Data – Presentation
Published: 2022-01-05 (Crawled : 10:00) - sutrobio.com
STRO M | $3.77 -0.79% -1.06% 770K

| -73.92% | O: -20.18% H: 0.0% C: -9.63%
stro-002 expansion presentation phase 1 phase 2 phase 3

| -73.33% | O: 5.05% H: 2.02% C: -2.67%
stro-002 treatment biopharma expansion drug ovarian cancer cancer antibody

Sutro Biopharma Announces Expansion of Leadership Team
Published: 2021-09-16 (Crawled : 11:20) - sutrobio.com
STRO M | $3.77 -0.79% -1.06% 770K

| -80.99% | O: 0.5% H: 0.5% C: -0.55%
NKTR | $1.32 -2.22% -3.85% 2.4M

| -91.66% | O: 0.19% H: 0.65% C: 0.31%
biopharma expansion

59%

41%

AGBA | News | $1.03 157.5% 57.94% 120M

ZCMD | $1.45 5.84% 52.1% 2.3M

INVO | $1.52 100.0% 51.13% 5M

ISPC | $0.421 97.65% 49.53% 37M

WLGS | News | $0.5 45.65% 470K

OST | $0.509 23.81% 45.26% 90K

GDHG | $0.263 21.76% 40.66% 3.1M

XPON | News | $3.15 63.21% 37.74% 16M

TIRX | $0.8 65.02% 30.74% 58M

BNTC | News | $6.82 42.08% 30.64% 3.5M

Save your searches and get alerts when important news are released.